4D-150 in Patients With Diabetic Macular Edema
Part of paid clinical trials in Hagerstown, Maryland.
- Sponsor
- 4D Molecular Therapeutics
- Study ID
- NCT05930561
- Phase
- PHASE2
- Status
- Active Not Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- 4D-150 IVT — BIOLOGICAL4D-150: AAV-based gene therapy comprised of miRNA targeting VEGF-C and codon-optimized sequence encoding aflibercept.
- Aflibercept IVT — BIOLOGICALCommercially available Active Comparator
Study Details
Phase 2 randomized, active-controlled, double-masked, dose-ranging trial in adults with Diabetic Macular Edema (DME).
Key Dates
- Start date
- Aug 9, 2023
- Status verified
- Sep 2025
- Primary completion
- Feb 28, 2029
- Completion
- Feb 28, 2029
Study Design
- Enrollment
- 72 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: 4D-150 Part 1 Dose Confirmation Dose Level 14D-150 will be administered at the assigned dose level as a single dose IVT injection on Day 1.
- Experimental: 4D-150 Part 1 Dose Confirmation Dose Level 24D-150 will be administered at the assigned dose level as a single dose IVT injection on Day 1.
- Experimental: 4D-150 Part 2 Dose Expansion Dose Level 14D-150 will be administered at the assigned dose level as a single dose IVT injection on Day 1.
- Experimental: 4D-150 Part 2 Dose Expansion Dose Level 24D-150 will be administered at the assigned dose level as a single dose IVT injection on Day 1.
- Active Comparator: 4D-150 Part 2 Dose Expansion ControlAflibercept at a fixed regimen will be administered.
Primary Outcome Measure
Incidence and severity of TEAEs and SAEs, including clinically significant changes in safety parameters (Part 1) [ Time Frame: 60 months ]
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cumberland Valley Retina Consultants | Hagerstown | Maryland | 21740 | - |
| Verum Research, LLC | Eugene | Oregon | 97401 | - |
| Erie Retina Research | Erie | Pennsylvania | 16507 | - |
| Austin Clinical Research | Austin | Texas | 78750 | - |
| Piedmont Eye Center | Lynchburg | Virginia | 24502 | - |
Find similar trials in Hagerstown, MD
By condition
By specialty
Related Studies
- National Eye Institute Biorepository for Retinal DiseasesRecruiting · National Eye Institute (NEI) · Bethesda, Maryland
- Optical Coherence Tomography Angiography in Subjects With Retinal Vascular DiseaseRecruiting · Johns Hopkins University · Baltimore, Maryland
- Fenofibrate for Prevention of DR WorseningPHASE3 · Recruiting · Jaeb Center for Health Research · Glendale, California
- Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)PHASE1 · Recruiting · Ocugen · Deerfield Beach, Florida